Dr. Frederick Beddingfield, Founder, President and Chief Executive Officer of Sienna Biopharmaceuticals, a clinical-stage medical dermatology and aesthetics company, talks about the company’s focus on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. Dr. Beddingfield tells a compelling story about Sienna and also discusses the clinical trials the company has underway.
Dr. Frederick C. Beddingfield, III, M.D., Ph.D. has been the Chief Executive Officer (CEO) and President of Sienna Labs, Inc. since January 2016. Dr. Beddingfield has been the Chief Medical Officer of Kythera Biopharmaceuticals, Inc. since March 23, 2013. Dr. Beddingfield joined KYTHERA from Allergan, Inc., which he joined in 2003. He has served as Vice President and Global Therapeutic Area Head of Dermatology and Aesthetics since August 2005, as well as Chief Medical Officer of Allergan Medical from August 2008 through December 2010. Since 2001, Dr. Beddingfield has also served as an Assistant Clinical Professor of Medicine, Division of Dermatology, at the David Geffen School of Medicine at UCLA. He has been the Director of Sienna Labs, Inc. since August 2015. He received his M.D. from the University of North Carolina at Chapel Hill and a Bachelor of Arts in Psychology from North Carolina State University in Raleigh, N.C. In addition, Dr. Beddingfield holds a Ph.D. in Policy Analysis from the RAND Graduate School of Policy Studies. He is a Board-Certified Dermatologist.